Left ventricular mass regression with amlodipine in elderly hypertensives

Area of Science:

• Cardiology
• Pharmacology
• Geriatrics

Background:

• Elderly hypertensive patients often exhibit left ventricular hypertrophy (LVH).
• Left ventricular mass and function are crucial indicators of cardiovascular health.
• Effective blood pressure control is essential in managing hypertension-related cardiac remodeling.

Purpose of the Study:

• To assess the impact of amlodipine on left ventricular (LV) mass and function in elderly hypertensive patients with LVH.
• To determine if amlodipine therapy leads to regression of LV mass.
• To evaluate changes in LV function following amlodipine treatment.

Main Methods:

• A prospective study involving 34 elderly hypertensive patients with echocardiographic evidence of LVH.
• Echocardiographic assessment of LV mass and function indices before and after 4 months of amlodipine therapy.
• Dosage adjustment of amlodipine to achieve effective blood pressure control.

Main Results:

• Fourteen patients completed the 4-month study period.
• Amlodipine effectively controlled blood pressure in all patients.
• Significant regression in LV mass indices, including interventricular septum thickness, left ventricular posterior wall thickness, and LV mass index, was observed.
• No significant alterations in LV function indices were detected post-treatment.

Conclusions:

• Amlodipine therapy is effective in controlling blood pressure in elderly hypertensive individuals.
• Amlodipine treatment leads to significant regression of left ventricular mass indices in patients with LVH.
• Amlodipine does not adversely affect left ventricular function in this patient group.